3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Breast Neoplasms
50
Carcinoma, Non-Small-Cell Lung
36
Ovarian Neoplasms
35
Stomach Neoplasms
32
Esophageal Neoplasms
29
Uterine Cervical Neoplasms
21
Esophageal Squamous Cell Carcinoma
19
Fallopian Tube Neoplasms
16
Lung Neoplasms
13
Carcinoma, Ovarian Epithelial
13
Neoplasms
9
Head and Neck Neoplasms
9
Carcinoma, Squamous Cell
9
Triple Negative Breast Neoplasms
8
Recurrence
8
Neoplasm Metastasis
6
Endometrial Neoplasms
6
Advanced Gastric Cancer
6
Squamous Cell Carcinoma of Head and Neck
5
Pancreatic Neoplasms
5
Nasopharyngeal Neoplasms
5
Hypopharyngeal Neoplasms
4
Oropharyngeal Neoplasms
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Melanoma
3
Laryngeal Neoplasms
3
Carcinoma
3
Anus Neoplasms
3
Adenocarcinoma Of Esophagus
3
Interventions
Paclitaxel
1
Decitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Primary Malignant Neoplasm of Ovary
×
Paclitaxel
×
Clear all
NCT02159820
2014-06-10
DAC and CT
Chinese PLA General Hospital
Phase 2/3
Unknown
500 enrolled